Cargando…

Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model

BACKGROUND: Specific highly polarized aquaporin‐4 (AQP4) expression is reported to play a crucial role in blood‐brain barrier (BBB) integrity and brain water transport balance. The upregulation of polymerase δ‐interacting protein 2 (Poldip2) was involved in aggravating BBB disruption following ische...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Meng, Lu, Weitian, Shu, Yue, Yang, Zhengyu, Sun, Shanquan, Xu, Jin, Gan, Shengwei, Zhu, Shujuan, Qiu, Guoping, Zhuo, Fei, Xu, Shiye, Wang, Yiying, Chen, Junhong, Wu, Xuan, Huang, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702237/
https://www.ncbi.nlm.nih.gov/pubmed/32790044
http://dx.doi.org/10.1111/cns.13446
_version_ 1783616573486923776
author Gao, Meng
Lu, Weitian
Shu, Yue
Yang, Zhengyu
Sun, Shanquan
Xu, Jin
Gan, Shengwei
Zhu, Shujuan
Qiu, Guoping
Zhuo, Fei
Xu, Shiye
Wang, Yiying
Chen, Junhong
Wu, Xuan
Huang, Juan
author_facet Gao, Meng
Lu, Weitian
Shu, Yue
Yang, Zhengyu
Sun, Shanquan
Xu, Jin
Gan, Shengwei
Zhu, Shujuan
Qiu, Guoping
Zhuo, Fei
Xu, Shiye
Wang, Yiying
Chen, Junhong
Wu, Xuan
Huang, Juan
author_sort Gao, Meng
collection PubMed
description BACKGROUND: Specific highly polarized aquaporin‐4 (AQP4) expression is reported to play a crucial role in blood‐brain barrier (BBB) integrity and brain water transport balance. The upregulation of polymerase δ‐interacting protein 2 (Poldip2) was involved in aggravating BBB disruption following ischemic stroke. This study aimed to investigate whether Poldip2‐mediated BBB disruption and cerebral edema formation in mouse bacterial meningitis (BM) model occur via induction of AQP4 polarity loss. METHODS AND RESULTS: Mouse BM model was induced by injecting mice with group B hemolytic streptococci via posterior cistern. Recombinant human Poldip2 (rh‐Poldip2) was administered intranasally at 1 hour after BM induction. Small interfering ribonucleic acid (siRNA) targeting Poldip2 was administered by intracerebroventricular (i.c.v) injection at 48 hours before BM induction. A specific inhibitor of matrix metalloproteinases (MMPs), UK383367, was administered intravenously at 0.5 hour before BM induction. Western blotting, immunofluorescence staining, quantitative real‐time PCR, neurobehavioral test, brain water content test, Evans blue (EB) permeability assay, transmission electron microscopy (TEM), and gelatin zymography were carried out. The results showed that Poldip2 was upregulated and AQP4 polarity was lost in mouse BM model. Both Poldip2 siRNA and UK383367 improved neurobehavioral outcomes, alleviated brain edema, preserved the integrity of BBB, and relieved the loss of AQP4 polarity in BM model. Rh‐Poldip2 upregulated the expression of MMPs and glial fibrillary acidic protein (GFAP) and downregulated the expression of β‐dystroglycan (β‐DG), zonula occludens‐1 (ZO‐1), occludin, and claudin‐5; whereas Poldip2 siRNA downregulated the expression of MMPs and GFAP, and upregulated β‐DG, ZO‐1, occludin, and claudin‐5. Similarly, UK383367 downregulated the expression of GFAP and upregulated the expression of β‐DG, ZO‐1, occludin, and claudin‐5. CONCLUSION: Poldip2 inhibition alleviated brain edema and preserved the integrity of BBB partially by relieving the loss of AQP4 polarity via MMPs/β‐DG pathway.
format Online
Article
Text
id pubmed-7702237
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77022372020-12-03 Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model Gao, Meng Lu, Weitian Shu, Yue Yang, Zhengyu Sun, Shanquan Xu, Jin Gan, Shengwei Zhu, Shujuan Qiu, Guoping Zhuo, Fei Xu, Shiye Wang, Yiying Chen, Junhong Wu, Xuan Huang, Juan CNS Neurosci Ther Original Articles BACKGROUND: Specific highly polarized aquaporin‐4 (AQP4) expression is reported to play a crucial role in blood‐brain barrier (BBB) integrity and brain water transport balance. The upregulation of polymerase δ‐interacting protein 2 (Poldip2) was involved in aggravating BBB disruption following ischemic stroke. This study aimed to investigate whether Poldip2‐mediated BBB disruption and cerebral edema formation in mouse bacterial meningitis (BM) model occur via induction of AQP4 polarity loss. METHODS AND RESULTS: Mouse BM model was induced by injecting mice with group B hemolytic streptococci via posterior cistern. Recombinant human Poldip2 (rh‐Poldip2) was administered intranasally at 1 hour after BM induction. Small interfering ribonucleic acid (siRNA) targeting Poldip2 was administered by intracerebroventricular (i.c.v) injection at 48 hours before BM induction. A specific inhibitor of matrix metalloproteinases (MMPs), UK383367, was administered intravenously at 0.5 hour before BM induction. Western blotting, immunofluorescence staining, quantitative real‐time PCR, neurobehavioral test, brain water content test, Evans blue (EB) permeability assay, transmission electron microscopy (TEM), and gelatin zymography were carried out. The results showed that Poldip2 was upregulated and AQP4 polarity was lost in mouse BM model. Both Poldip2 siRNA and UK383367 improved neurobehavioral outcomes, alleviated brain edema, preserved the integrity of BBB, and relieved the loss of AQP4 polarity in BM model. Rh‐Poldip2 upregulated the expression of MMPs and glial fibrillary acidic protein (GFAP) and downregulated the expression of β‐dystroglycan (β‐DG), zonula occludens‐1 (ZO‐1), occludin, and claudin‐5; whereas Poldip2 siRNA downregulated the expression of MMPs and GFAP, and upregulated β‐DG, ZO‐1, occludin, and claudin‐5. Similarly, UK383367 downregulated the expression of GFAP and upregulated the expression of β‐DG, ZO‐1, occludin, and claudin‐5. CONCLUSION: Poldip2 inhibition alleviated brain edema and preserved the integrity of BBB partially by relieving the loss of AQP4 polarity via MMPs/β‐DG pathway. John Wiley and Sons Inc. 2020-08-12 /pmc/articles/PMC7702237/ /pubmed/32790044 http://dx.doi.org/10.1111/cns.13446 Text en © 2020 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Gao, Meng
Lu, Weitian
Shu, Yue
Yang, Zhengyu
Sun, Shanquan
Xu, Jin
Gan, Shengwei
Zhu, Shujuan
Qiu, Guoping
Zhuo, Fei
Xu, Shiye
Wang, Yiying
Chen, Junhong
Wu, Xuan
Huang, Juan
Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model
title Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model
title_full Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model
title_fullStr Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model
title_full_unstemmed Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model
title_short Poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model
title_sort poldip2 mediates blood‐brain barrier disruption and cerebral edema by inducing aqp4 polarity loss in mouse bacterial meningitis model
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702237/
https://www.ncbi.nlm.nih.gov/pubmed/32790044
http://dx.doi.org/10.1111/cns.13446
work_keys_str_mv AT gaomeng poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel
AT luweitian poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel
AT shuyue poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel
AT yangzhengyu poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel
AT sunshanquan poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel
AT xujin poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel
AT ganshengwei poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel
AT zhushujuan poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel
AT qiuguoping poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel
AT zhuofei poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel
AT xushiye poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel
AT wangyiying poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel
AT chenjunhong poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel
AT wuxuan poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel
AT huangjuan poldip2mediatesbloodbrainbarrierdisruptionandcerebraledemabyinducingaqp4polaritylossinmousebacterialmeningitismodel